Panel Discussion: Cath Lab Innovations

Monday, February 27, 2023

10:00 AM – 10:30 AM ET

Panel Moderator(s)

Sam Chitsaz, MD FACC FSCAI

Interventional Cardiologist
Sutter Health

No relationships to disclose
Chaim Shaul Lotan, MD

Director Heart Institute
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

No relationships to disclose

Panel Discussant(s)

Tim A. Fischell, MD, FACC

Director of Cardiovascular Research
Ascension Borgess Heart Institute
Kalamazoo, Michigan, United States

Disclosure(s): Ablative Solutions, Inc.: Employee (Ongoing), Intellectual Property/Patents (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Patent Holder (Ongoing), Royalties (Ongoing), Salary (Ongoing); Angel Medical Systems, Inc.: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Royalties (Ongoing); Vantis Vascular, Inc.: Board Member (Ongoing), Employee (Ongoing), Intellectual Property/Patents (Ongoing), Patent Holder (Ongoing), Salary (Ongoing)
Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

Interventional Cardiologist
John Muir Health Cardiovascular Institute
San Francisco, California, United States

Disclosure(s): AtaCor Medical: Minor stock options (Ongoing), Scientific Advisory Board (Ongoing)
Andrew M. Goldsweig, MD, MS

Associate Professor; Medical Director, Structural Heart Disease
University of Nebraska Medical Center
Omaha, Nebraska, United States

Disclosure(s): Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Robert S. Schwartz, MD, FACC, FSCAI

President
DeHaan Center for Medical Innovation
Longboat Key, Florida, United States

Disclosure(s): Corflow: Holder of Intellectual Property Rights (Ongoing), Major Stockholder (not including mutual funds) (Ongoing); Lifelens LLC: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing)

Disclosure(s):

Tim A. Fischell, MD, FACC: Ablative Solutions, Inc.: Employee (Ongoing), Intellectual Property/Patents (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Patent Holder (Ongoing), Royalties (Ongoing), Salary (Ongoing); Angel Medical Systems, Inc.: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Royalties (Ongoing); Vantis Vascular, Inc.: Board Member (Ongoing), Employee (Ongoing), Intellectual Property/Patents (Ongoing), Patent Holder (Ongoing), Salary (Ongoing)

Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC: AtaCor Medical: Minor stock options (Ongoing), Scientific Advisory Board (Ongoing)

Andrew M. Goldsweig, MD, MS: Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Robert S. Schwartz, MD, FACC, FSCAI: Corflow: Holder of Intellectual Property Rights (Ongoing), Major Stockholder (not including mutual funds) (Ongoing); Lifelens LLC: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing)